AI-generated summary
The authors report a case study of a 59-year-old man with mild Alzheimer's disease and type 2 diabetes who followed a 10-week ketogenic nutrition protocol combined with transcranial photobiomodulation. They report improved metabolic markers and a cognitive score change on the MoCA. As a single-patient case report without a control group, these findings cannot establish whether the intervention caused the changes.
- Participants
- 1
- Who or what was studied
- A single 59-year-old male with mild Alzheimer's disease, heterozygous ApoE4 carrier, and an 11-year history of insulin-dependent type 2 diabetes
- Limits stated in the abstract
- Single case report with one participant and no control group, so causality and generalizability cannot be established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Mild cognitive impairment, Mitochondria, Case report, Montreal Cognitive Assessment, Near-infrared, Transcranial photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.